United States: CMS Unveils New Mandatory Medicare Bundled Payment Models For Cardiac & Hip Fracture Cases, Plus Proposed Refinements To CJR Program

On July 25, 2016, CMS announced ambitious, multi-pronged plans to expand mandatory Medicare coordinated care/bundled payment programs, promote the use of cardiac rehabilitation services, refine current Comprehensive Care for Joint Replacement Model (CJR) rules, and integrate bundled payment programs into the upcoming Medicare physician quality/payment framework. The proposed "Advancing Care Coordination through Episode Payment Model" rule is part of the Administration's efforts to move the Medicare system away from fee-for-service (FFS) payments and towards alternative payment models that reward quality of care rather than volume of services.

The new policies are set forth in a 906-page proposed rule that is scheduled to be published in the Federal Register on August 2, 2016. Comments on the rule will be accepted for 60 days from the date of publication.

The following are the major components of the proposed rule; Reed Smith is preparing a more detailed analysis of the program.

New Mandatory Episode Payment Models for Cardiac Care, Hip Fractures

CMS proposes to test three new Medicare Parts A and B bundled payment models – which it calls "episode payment models" (EPMs) – for episodes of care surrounding an acute myocardial infarction (AMI), coronary artery bypass graft (CABG), and surgical hip/femur fracture treatment excluding lower extremity joint replacement (SHFFT). The goal for the proposed EPMs is to improve the quality of care provided to beneficiaries in an applicable episode while reducing episode spending through financial accountability. Like the CJR program on which these models are patterned, participation in the new EPMs would be mandatory in selected geographic areas. CMS expects the EPMs to result in Medicare savings of $170 million over five years.

CMS proposes to test the proposed EPMs for five performance years (PYs), beginning July 1, 2017 and ending December 31, 2021. Under the proposed rule, CMS would designate 98 randomly-selected metropolitan statistical areas (MSAs) for the CABG and AMI EPMs. CMS plans to test the SHFFT EPM in the same 67 MSAs in which CJR is currently operating.

Under the proposed EPMs, an AMI, CABG, or SHFFT model episode would begin with an inpatient admission to an "anchor hospital" for a specified Medicare Severity-Diagnosis Related Group (MS-DRG):

AMI episodes: AMI MS-DRGs 280-282 and Percutaneous Coronary Intervention (PCI) MS-DRGs 246-251 representing IPPS admissions for AMI that are treated with PCIs

CABG episodes: MS-DRGs 231-236

SHFFT episodes: MS-DRGs 480-482

The episode would end 90 days after the date of discharge. The episode would include the inpatient stay and all related care covered under Medicare Parts A and B within the 90 days after discharge, including hospital care, post-acute care, and physician services, with very limited exceptions.

As under the current CJR program, the acute care hospital would be the "episode initiator" and bear financial risk under the proposed EPMs. During the duration of the program, CMS would continue to pay hospitals and other providers and suppliers according to the usual Medicare FFS rules. At the completion of a PY, CMS would compare (1) actual Medicare claims data for service furnished to beneficiaries during the episode, to (2) a quality-adjusted target price based on historical data with various adjustments with a discount to reflect savings to Medicare. The target price initially would be based on a blend of hospital-specific and regional historical data, transitioning to only regional data for PY4 and PY5. Hospitals that deliver care for less than the quality-adjusted target price and meet applicable quality standards would be eligible for a "reconciliation payment"; hospitals with costs that exceed the quality-adjusted target price would be required to repay Medicare after a phase-in period beginning in the second quarter of PY2. A number of other factors also would be considered in determining reconciliation and repayment amounts, including quality scores, certain transfers and readmissions of beneficiaries to inpatient hospitals for these episodes and various limits on the hospital gains and losses during reconciliation. The following is the phase-in schedule, with limits on repayments and gains:

Repayment Limits (payments from hospital to Medicare):

  • July 2017 – March 2018 (PY1 and quarter 1 of PY2): No repayment
  • April 2018 – December 2018 (quarters 2 through 4 of PY2): Capped at 5 percent
  • 2019 (PY3): Capped at 10 percent
  • 2020 – 2021 (PY4 and PY5): Capped at 20 percent

Reconciliation Payment Limits (payments from Medicare to hospitals):

  • July 2017 – December 2018 (PY1 and PY2): Capped at 5 percent
  • 2019 (PY3): Capped at 10 percent
  • 2020 – 2021 (PY4 and PY5): Capped at 20 percent

As under the CJR program, CMS anticipates that EPM participant hospitals will enter into gainsharing arrangements with other providers and suppliers. Moreover, CMS proposes to add other hospitals as potential collaborators, along with accountable care organizations (ACOs). CMS also proposes to provide hospitals with additional utilization and spending data to help improve care coordination. The proposed rule discusses the extent to which CMS will waive certain Medicare program rules to promote coordination of care. While some policies, such as telehealth originating site requirements, would be waived for all three proposed EPMs, CMS proposes to make model-specific decisions about other waivers, including waivers of the skilled nursing facility 3-day stay requirement and post-discharge nursing visit limits.

Cardiac Rehabilitation Model

CMS also proposes to establish a Cardiac Rehabilitation (CR) incentive payment model to test the use of CR and intensive cardiac rehabilitation (ICR) services for beneficiaries hospitalized for treatment of an AMI or CABG for 90 days post-hospital discharge. CMS proposes to make the CR incentive payments available to hospital participants in 45 geographic areas that were selected for the CABG and AMI EPMs and 45 geographic areas that were not selected for the EPM program. The CR model will span the same five-year period as the cardiac care EPMs.

CMS proposes to make standard Medicare payments for CR/ICR services (HCPCS codes 93797, 93798, G0422, and G0423) at the time of service, with an additional retrospective payment to participant hospitals based on total CR service use:

  • CMS would make an initial payment of $25 per CR/ICR service for each of the first 11 CR/ICR services paid for by Medicare during an AMI or CABG model episode or an AMI or CABG care period.
  • After 11 CR/ICR services are paid for by Medicare for a beneficiary, the level of the per-service CR incentive amount would increase to $175 per CR/ICR service for each additional CR/ICR service paid for by Medicare during the AMI or CABG model episode or AMI care period or CABG care period.

CMS proposes certain limits on services and conditions of coverage for such services.

CMS estimates a total aggregate impact between $27 million in net Medicare costs and $32 million in net Medicare savings from July 2017-December 2024 as a result of the CR incentive payment model; CMS notes that this range of potential impacts is due to uncertainty regarding the extent to which CR/ICR utilization will increase based on the proposed CR incentive.

Integration of Bundled Payment Models within MACRA Physician Quality Payment Program

CMS proposes that physician collaboration with hospitals participating in the new cardiac care and hip fracture EPMs (along with the ongoing CJR program) could qualify as participation in an Advanced Alternative Payment Model (APM) for purposes of the Medicare Access and CHIP Reauthorization Act (MACRA) physician payment and quality reform provisions, beginning in 2018. CMS proposes different rules for the Advanced APM "track," including use of certified health information technology functions and assumption of financial risk.

Revisions to CJR Rules

The proposed rule includes a number of changes to CJR program rules, including: enabling the CJR model to potentially qualify as an Advanced APM; allowing ACOs, critical access hospitals, and hospitals to be CJR collaborators; and other provisions related to financial arrangements, pricing, the reconciliation process, and composite scoring. CMS estimates that the proposed changes in the CJR model will increase estimated costs to the Medicare program by $35 million over the duration of the CJR (April 2016-December 2020) compared to CMS's estimate in the CJR final rule.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions